NASSCOM GCC Summit 2025

What’s Next for Global Capability Centers (GCCs)? Cactus Life Sciences at the NASSCOM GCC Summit 2025

The theme for this year’s NASSCOM GCC Summit, “The Next GCC Frontier: Ambition, Agility, Ascent,” couldn’t have been more apt. Held in Hyderabad on April 22–23, 2025, the event brought together visionary leaders, strategists, technologists, and innovators to examine the evolving role of India’s global capability centers (GCCs) and their journey from execution engines to…...
Read More

Top Stories

“Voice of Patient” in Publications: Trends and

This page contains a poster presented at the 21st Annual...
MAPS 2025

MAPS 2025 Decoded: The Medical Affairs Playbook

At the MAPS Americas 2025 conference in New Orleans, one of...
DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for

Digital and AI were hot topics underpinning many of the...
Periodic Safety Update Report (PSUR) - Medical Device

Periodic Safety Update Report (PSUR): A Breakdown of MDCG 2022-21

A well-structured, clear, and concise PSUR enables a seamless notified body review. Read our key...
HEOR Pharma Payers

Didactic to Dynamic: Innovative Approaches to Deeper Payer Engagements

HEOR is a fast-evolving field. Feedback from payers can influence research plans and help create...
Medical Device Regulation

Clinical Evidence: How Much Is Enough?

Ensuring the safety and functionality of your medical device is vital. But how much clinical...
Data-driven QMS Alignment-Feature image for the 30-sec video reel - AMDS

Medical Device Manufacturing: Risk-Based QMS Alignment for EU MDR

The latest EU-MDR guidelines are a step in the right direction, moving from a focus...
Plain Language Clinical Trial Summaries

Why Do Plain Language Clinical Trial Summaries Matter?

Did you know that the European Medicines Agency’s Clinical Trials Regulation comes into effect on...
Stakeholder perspectives on digital scientific content

Digital Scientific Content: Stakeholder Perspectives

What do the different relevant stakeholder groups truly expect from pharma-generated scientific content?...

Learn more ABOUT our company.